LV5268A3 - pristinamicina atvasinajumu iegusanas panemiens - Google Patents

pristinamicina atvasinajumu iegusanas panemiens

Info

Publication number
LV5268A3
LV5268A3 LV930070A LV930070A LV5268A3 LV 5268 A3 LV5268 A3 LV 5268A3 LV 930070 A LV930070 A LV 930070A LV 930070 A LV930070 A LV 930070A LV 5268 A3 LV5268 A3 LV 5268A3
Authority
LV
Latvia
Prior art keywords
formula
derivatives
promotes
acquisition
image
Prior art date
Application number
LV930070A
Other languages
English (en)
Latvian (lv)
Inventor
Jean-Claude Barriere
Claude Cotrel
Jean-Marc Paris
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of LV5268A3 publication Critical patent/LV5268A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Vibration Prevention Devices (AREA)
  • Measurement Of Force In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polarising Elements (AREA)
LV930070A 1986-05-22 1993-01-26 pristinamicina atvasinajumu iegusanas panemiens LV5268A3 (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8607270A FR2599036B1 (fr) 1986-05-22 1986-05-22 Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
SU874202596A SU1616520A3 (ru) 1986-05-22 1987-05-21 Способ получени производных пристинамицина

Publications (1)

Publication Number Publication Date
LV5268A3 true LV5268A3 (lv) 1993-10-10

Family

ID=9335470

Family Applications (1)

Application Number Title Priority Date Filing Date
LV930070A LV5268A3 (lv) 1986-05-22 1993-01-26 pristinamicina atvasinajumu iegusanas panemiens

Country Status (25)

Country Link
US (1) US4798827A (xx)
EP (1) EP0248703B1 (xx)
JP (2) JP2558282B2 (xx)
KR (1) KR950001020B1 (xx)
AT (1) ATE63563T1 (xx)
AU (1) AU601426B2 (xx)
BR (1) BR1101133A (xx)
CA (1) CA1271297A (xx)
DE (2) DE10075012I2 (xx)
DK (1) DK172949B1 (xx)
ES (1) ES2032457T3 (xx)
FI (1) FI84355C (xx)
FR (1) FR2599036B1 (xx)
GE (1) GEP19960474B (xx)
GR (1) GR3002558T3 (xx)
IE (1) IE60656B1 (xx)
IL (1) IL82564A (xx)
LU (1) LU90732I2 (xx)
LV (1) LV5268A3 (xx)
MX (1) MX9203577A (xx)
NL (1) NL300010I2 (xx)
NZ (1) NZ220380A (xx)
PT (1) PT84934B (xx)
SU (1) SU1616520A3 (xx)
ZA (1) ZA873639B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664894A1 (fr) * 1990-07-19 1992-01-24 Rhone Poulenc Sante Nouveaux derives de streptogramines et leur preparation.
FR2689518B1 (fr) 1992-04-01 1995-04-07 Rhone Poulenc Rorer Sa Microorganismes, procédé de préparation et utilisation.
US5242938A (en) * 1992-08-27 1993-09-07 Merck & Co., Inc. Derivatives of virginiamycin M1
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
FR2723373B1 (fr) 1994-08-02 1996-09-13 Rhone Poulenc Rorer Sa Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
FR2766489B1 (fr) 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
US6187746B1 (en) * 1997-12-16 2001-02-13 Rhone-Poulenc Rorer S.A. Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
FR2796949B1 (fr) * 1999-07-27 2001-09-21 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549064B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines utiles pour la preparation de nouveaux medicaments antimicrobiens et leur preparation
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2549063B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2549062B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FI84355B (fi) 1991-08-15
IE871317L (en) 1987-11-22
KR880013934A (ko) 1988-12-22
IL82564A0 (en) 1987-11-30
JP2659531B2 (ja) 1997-09-30
FI84355C (fi) 1991-11-25
DK172949B1 (da) 1999-10-11
JPH08319236A (ja) 1996-12-03
IL82564A (en) 1991-04-15
ES2032457T3 (es) 1993-02-16
FR2599036A1 (fr) 1987-11-27
IE60656B1 (en) 1994-08-10
KR950001020B1 (ko) 1995-02-07
DE10075012I2 (de) 2006-02-02
FI872236A0 (fi) 1987-05-21
ZA873639B (en) 1987-11-17
DE3770048D1 (de) 1991-06-20
BR1101133A (pt) 1999-12-07
LU90732I2 (en) 2001-04-17
SU1616520A3 (ru) 1990-12-23
CA1271297A (fr) 1990-07-03
AU7323987A (en) 1987-11-26
FI872236A (fi) 1987-11-23
GEP19960474B (en) 1996-07-22
DE10075012I1 (de) 2000-08-31
EP0248703A1 (fr) 1987-12-09
DK258587D0 (da) 1987-05-21
AU601426B2 (en) 1990-09-13
NL300010I1 (nl) 2000-08-01
PT84934A (fr) 1987-06-01
MX9203577A (es) 1992-09-01
PT84934B (pt) 1990-02-08
GR3002558T3 (en) 1993-01-25
US4798827A (en) 1989-01-17
FR2599036B1 (fr) 1988-09-09
NZ220380A (en) 1989-02-24
JPS6322095A (ja) 1988-01-29
ATE63563T1 (de) 1991-06-15
DK258587A (da) 1987-11-23
NL300010I2 (nl) 2001-01-02
EP0248703B1 (fr) 1991-05-15
JP2558282B2 (ja) 1996-11-27

Similar Documents

Publication Publication Date Title
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
LV5268A3 (lv) pristinamicina atvasinajumu iegusanas panemiens
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
MX9204613A (es) Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares
SE8302751L (sv) 2(1h)-pyridinonderivat, deras framstellning och farmaceutiska beredningar som innehaller dem
ES2039291T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas y su empleo.
NO871575L (no) Fremgangsmaate for fremstilling av 1,5-benztiazepin-derivater.
DK583084A (da) (3-aryl-2,3-dihydrobenzofuran-3-yl)-alkylaminer, deres fremstilling og anvendelse som laegemidler
ES2106866T3 (es) Nuevos derivados de 2h-benzo(b)pirano sustituidos en la posicion 4 por arilo o n-heteroarilo, procedimiento para su preparacion y su uso, asi como preparados que contienen los compuestos.
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
BR7902860A (pt) Novos derivados de 1,5-dimetil biciclo(3,2,1)octano,preparacao destes compostos,e seu uso com compostos de perfume
DK0401093T3 (da) Hidtil ukendte pyrrolidonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse
IL86722A0 (en) Guanidine-related compounds comprising a tetraphenylborate ion,their preparation and their use
NO903585L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
ES2037825T3 (es) Uso farmaceutico de tioeteres aromaticos.
ES2063561T3 (es) 6-tiono-5,6-dihidro-dibenz(b,e)azepin-11-on-11-oximas y su uso como agentes retrovirales.
DE3674060D1 (de) Pharmacologisch aktive propionylanilide.
MX169275B (es) Proceso para la preparacion de derivados de 6-deoxi guanidina